Passive Aβ Immunotherapy: Current Achievements and Future Perspectives

Passive immunotherapy has emerged as a very promising approach for the treatment of Alzheimer’s disease and other neurodegenerative disorders, which are characterized by the misfolding and deposition of amyloid peptides. On the basis of the amyloid hypothesis, the majority of antibodies in cli...

Celý popis

Podrobná bibliografie

Hlavní autoři:	Stephan Schilling, Jens-Ulrich Rahfeld, Inge Lues, Cynthia A. Lemere
Médium:	Artigo
Jazyk:	Inglês
Vydáno:	MDPI AG 2018-05-01
Edice:	Molecules
Témata:	amyloid-β monoclonal antibodies posttranslational modifications drug development
On-line přístup:	http://www.mdpi.com/1420-3049/23/5/1068
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!